000 | 01075na a2200241 4500 | ||
---|---|---|---|
003 | PC5705 | ||
005 | 20180113071643.0 | ||
008 | 130622s2011 xxx||||| |||| 00| 0 eng d | ||
040 | _cH12O | ||
041 | _aeng | ||
100 |
_91500 _aRubio García, Rafael _eUnidad de VIH |
||
245 | 0 | 0 |
_aIntensification of antiretroviral therapy with a CCR5 antagonist in patients with chronic HIV-1 infection: effect on T cells latently infected _h[artículo] |
260 |
_bPLoS One, _c2011 |
||
300 | _a6(12):e27864. | ||
337 | _a | ||
500 | _aFormato Vancouver: Gutiérrez C, Díaz L, Vallejo A, Hernández-Novoa B, Abad M, Madrid N, et al. Intensification of antiretroviral therapy with a CCR5 antagonist in patients with chronic HIV-1 infection: effect on T cells latently infected. PLoS One. 2011;6(12):e27864. | ||
501 | _aPMID: 22174752 | ||
504 | _aContiene 50 referencias. | ||
710 |
_96 _aServicio de Medicina Interna |
||
710 |
_9395 _aServicio de Inmunología |
||
856 |
_u http://repositorio.papi.h12o.es/pdf/pc5705.pdf _ySolicitar documento |
||
942 |
_2ddc _cART _n0 |
||
999 |
_c5705 _d5705 |